Patents Assigned to AlphaGene, Inc.
  • Publication number: 20020019006
    Abstract: A method is provided for the rapid identification of protein-protein interaction networks within a cell, tissue, or whole genome. The introduction of a multi-bait approach is a distinguishing feature of the technology. In this method a pair of two-hybrid cDNA libraries, each one carrying the complement of genes from the tissue under study, are combined for an interaction screen. A large number of yeast colonies, each identifying a protein interaction pair, are picked and distributed in single wells, providing an arrayed archive of protein-protein interactions. The archive also serves as a source of plasmids to construct arrayed replicas containing DNA of the interacting plasmid pairs. Hybridization of a given cDNA to the arrayed replicas identifies the corresponding interacting clones. Protein interaction networks are constructed by iteration of the hybridization with newly identified interacting clones.
    Type: Application
    Filed: August 3, 2001
    Publication date: February 14, 2002
    Applicant: AlphaGene,Inc.
    Inventors: Olive Yi-lu Yuan, Dario B. Valenzuela, Peter Rapiejko, Heidi M. Hoffmann, kara Ann Higgins
  • Patent number: 5863563
    Abstract: Methods and compositions for the treatment of the symptoms of a patient who has a pulmonary condition associated with an inhibition of surfactant secretion by type II alveolar cells are described. The method of treatment involves causing a patient to inhale an amount of a pH-raising buffer effective to raise the pH of the aqueous fluid in the microenvironment of the type II alveolar cell lumenal surface, thereby inducing an increase in the rate of surfactant secretion by type II alveolar cells.
    Type: Grant
    Filed: October 20, 1994
    Date of Patent: January 26, 1999
    Assignee: AlphaGene Inc.
    Inventor: George Scheele
  • Patent number: 5663315
    Abstract: The invention features a method for diagnosis of pancreatitis by detecting an elevation in the amount of GP2 pancreatic glycoprotein in a sample of bodily fluid such as human blood, serum, or urine. The invention also features isolated DNA encoding human GP2, a method for producing recombinant human GP2, antibodies which specifically bind to human GP2, a method for producing anti-human GP2 antibodies, and a kit for use in the diagnosis of pancreatitis.
    Type: Grant
    Filed: December 6, 1994
    Date of Patent: September 2, 1997
    Assignee: AlphaGene, Inc.
    Inventors: George Scheele, Shin-Ichi Fukuoka